Fort Worth, Texas-based Alcon Laboratories has voluntarily recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, which are packaged in batches of 25.

Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...

The product may be used to treat a condition that the American Academy of Ophthalmology says affects around 20 million ...

Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...

Fungus in eye drops can cause eye infections, which may be vision-threatening, and potentially life-threatening in immunocompromised people. The FDA is urging consumers to stop using the eye drops ...

The Food and Drug Administration (FDA) announced a nationwide recall of a popular single-use eye drop on December 23. Alcon Laboratories, maker of Systane eyedrops, voluntarily recalled one lot of ...

the FDA added. This recall comes after a string of contamination-related eye drop recalls rolled out last year. Systane Lubricant Ultra PF eye drops are meant for the temporary relief of burning ...

the FDA added. This recall comes after a string of contamination-related eye drop recalls rolled out last year. Systane Lubricant Ultra PF eye drops are meant for the temporary relief of burning ...